Since making its debut on the local bourse seven months ago, Dis-Chem's share price has risen about 40%. Now the pharmaceutical retailer is looking to up the ante with acquisitions. CEO Ivan Saltzman said on Thursday that there were potential mergers and acquisitions in the pipeline for the group. He would not disclose details, but said that any acquisitions "would be aligned to what we do". Although it's early days for Dis-Chem on the JSE, the company, which was established in 1978, has big plans to expand to 200 stores in two to five years, a plan that Alec Abraham, a senior equity analyst at Sasfin Securities, described as "ambitious". "They've got quite ambitious store targets in terms of stores, so to open new stores is a tall order. "If they can buy pharmacies or small groups of pharmacies just to bump up the new store numbers, I certainly think that makes sense," said Abraham. "They've got 108 stores and they want to try and double that over the next two years, so that's goin...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now